|
"Truth Don?" e-mail header to Don with Sarah cc-ed in
|
9
|
Resverlogix Corp.
|
Jun 07, 2022 01:46PM
|
|
"FYI event tmr!" - from Sarah
|
2
|
Zenith Epigenetics
|
Mar 09, 2022 03:52PM
|
|
"FYI event tmr!" - from Sarah
|
7
|
Resverlogix Corp.
|
Mar 09, 2022 04:07PM
|
|
"expert market"??
|
2
|
Zenith Epigenetics
|
Nov 02, 2021 02:05PM
|
|
"Actively Recruiting" ?
|
1
|
Resverlogix Corp.
|
Nov 04, 2021 10:52AM
|
|
they don't call em
|
2
|
Resverlogix Corp.
|
Jun 21, 2022 06:01PM
|
|
something that looks somewhat positive?
|
2
|
Resverlogix Corp.
|
Oct 06, 2022 04:02PM
|
|
So when Don told us they had screened or were screening 14 people
|
7
|
Resverlogix Corp.
|
Jan 03, 2022 01:36PM
|
|
possible catalyst(s)??
|
3
|
Zenith Epigenetics
|
Dec 20, 2021 10:08AM
|
|
it's easy to see how the market has trouble wrapping its head around the Science
|
3
|
Resverlogix Corp.
|
Feb 12, 2020 09:44AM
|
|
bid/ask thus far $1.51 [53] $1.51 [69]
|
4
|
Resverlogix Corp.
|
Dec 06, 2019 09:09AM
|
|
Apabetalone Inhibits SARS-CoV-2 Infection at Levels Comparable to Approved Antiviral
|
5
|
Resverlogix Corp.
|
Mar 15, 2021 10:44AM
|
|
10 Most Fined Pharmaceutical Companies in the World
|
1
|
Resverlogix Corp.
|
Dec 20, 2023 12:06PM
|
|
" Resverlogix will conclude its Phase 2 trial in hospitalized COVID-19 patients early, thus focusing its resources on the advanced Phase 3 program."
|
4
|
Resverlogix Corp.
|
May 09, 2022 07:47AM
|
